Invention Grant
- Patent Title: Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
-
Application No.: US15626981Application Date: 2017-06-19
-
Publication No.: US10093663B2Publication Date: 2018-10-09
- Inventor: Christopher Michael Adams , Michael Paul Capparelli , Takeru Ehara , Rajeshri Ganesh Karki , Nello Mainolfi , Chun Zhang
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent David Kurlandsky
- Main IPC: C07D401/06
- IPC: C07D401/06 ; C07D403/06 ; C07D413/06 ; C07D401/14 ; C07D413/14 ; C07D417/14 ; A61K31/404 ; A61K31/438 ; A61K31/4439 ; A61K31/454 ; A61K31/5377 ; A61K31/55
Abstract:
The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
- US20180009795A1 Piperidinyl-Indole Derivatives Complement Factor B Inhibitors and Uses Thereof Public/Granted day:2018-01-11
Information query
